New Developments

Cartherics is preparing for Phase 1B Clinical Trials for relapsed ovarian cancer.

We have recently appointed some experts in clinical and regulatory developments.

Penny Field, MMed.Sc. (Drug Development), Regulatory Advisor.

· Brings over 25 years of experience in the development and registration of biopharmaceuticals.

· Expert in the regulatory strategy and Chemistry, Manufacturing and Controls (CMC) development of monoclonal antibodies, vaccines, immunotherapeutics, recombinant proteins and cell and gene therapies.

 

Dr Carrie van der Weyden MBBS (Hons) FRACP FRCPA

Clinical Haematologist and early career clinical researcher, with experience in phase I-III clinical trials, and an interest in cellular and immunotherapies, especially in the field of T cell lymphoma.